Free Trial

Synthomer (LON:SYNT) Issues Quarterly Earnings Results

Synthomer logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Synthomer reported a quarterly EPS of GBX (91.90) and remains loss-making with a negative net margin (‑4.49%) and negative ROE (‑8.05%).
  • Shares jumped 40.8% to GBX 97 on heavy volume after the results, and insider Lily Liu bought 29,192 shares at GBX 66, a move seen as a signal of management confidence.
  • The company is highly leveraged (debt‑to‑equity ~97.65%), making refinancing progress critical, while analysts largely rate the stock "Hold" with a consensus price target of GBX 81.75.
  • Five stocks to consider instead of Synthomer.

Synthomer (LON:SYNT - Get Free Report) announced its quarterly earnings results on Friday. The company reported GBX (91.90) EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 173.92 billion for the quarter. Synthomer had a negative return on equity of 8.05% and a negative net margin of 4.49%.

Synthomer Stock Up 40.8%

Shares of SYNT stock traded up GBX 28.10 during trading hours on Friday, reaching GBX 97. The company had a trading volume of 11,862,283 shares, compared to its average volume of 1,862,088. The company has a debt-to-equity ratio of 97.65, a quick ratio of 0.97 and a current ratio of 1.64. Synthomer has a twelve month low of GBX 16.70 and a twelve month high of GBX 123.74. The company has a market capitalization of £158.57 million, a P/E ratio of -1.90, a price-to-earnings-growth ratio of -0.17 and a beta of 0.57. The stock's fifty day simple moving average is GBX 33.76 and its 200 day simple moving average is GBX 47.44.

Insider Activity

In related news, insider Lily Liu bought 29,192 shares of the stock in a transaction dated Thursday, April 30th. The stock was acquired at an average price of GBX 66 per share, for a total transaction of £19,266.72. Company insiders own 5.03% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Jefferies Financial Group restated a "hold" rating and set a GBX 65 price target on shares of Synthomer in a research note on Thursday. Deutsche Bank Aktiengesellschaft lowered their target price on Synthomer from GBX 96 to GBX 62 and set a "hold" rating for the company in a research note on Monday, February 2nd. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of GBX 81.75.

View Our Latest Analysis on SYNT

Trending Headlines about Synthomer

Here are the key news stories impacting Synthomer this week:

  • Positive Sentiment: Refinancing relief reported; market reaction favors the stock because debt concerns eased following management actions and commentary, which investors see as lowering near‑term solvency risk. Article Title
  • Positive Sentiment: Company improving margins and cash flow as it sharpens focus on specialty polymers — operational improvements give investors a reason to price in recovery potential. Article Title
  • Positive Sentiment: Insider purchase: director Lily Liu bought 29,192 shares at GBX 66 (~£19,267), which investors view as a signal of management confidence. Article Title
  • Neutral Sentiment: Jefferies reaffirmed a "Hold" rating with a GBX 65 price target — no upgrade, so limited immediate upside from broker action. Article Title
  • Neutral Sentiment: Earnings-call transcript and slide deck are available for detail — useful for investors wanting management’s color on cash flow, refinancing and strategy execution. Earnings Transcript Slide Deck
  • Negative Sentiment: Quarterly results show GBX (91.90) EPS, negative net margin (‑4.49%) and negative ROE (‑8.05%) — the business is still loss-making and vulnerable if margin recovery stalls. Earnings Report
  • Negative Sentiment: High leverage (debt-to-equity ~98%) remains a material risk; refinancing progress matters for downside protection and will determine whether operational gains are enough to restore profitability. Financials Snapshot

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines